As Black, Native American, and Latinx people continue to experience much higher rates of death due to COVID-19, these communities are still receiving fewer vaccines.
No expanded Medicaid. Awful sex ed. Criminalization laws. And poor PrEP access. But folks are making do—and taking part in systemic political change where they can.
The fight for places where drug users can shoot up safely isn’t over—but it’s competing with an effort to expand access to medications that block addiction.
We talked with longtime HIV/AIDS policy expert and former ONAP official Greg Millett, M.P.H., to better understand why.
Late last year, the Texas health department asked the authors to take “white supremacy” out of the abstract—and then dropped it altogether.
Advocates say that a big fat COVID bill must come first, followed by a Medicare public option. (Oh ... and then there’s impeachment.)
New York State HIV and Health Providers Are Terrified of This Impending Cut From Gov. Cuomo’s Office
Activists and health care providers say that planned cuts in the Medicaid 340B program will decimate their funding for crucial services to vulnerable populations during COVID—and destroy the state’s goal of ending the HIV epidemic.
It’s a way of analyzing the genetic makeup of different people’s HIV to draw connections among cases for prevention purposes—but some are worried it could be used to criminalize people with HIV.
What would happen if we doubled the budget for an HIV cure? It would still be far less money than has already been spent on COVID-19 vaccines. Both are worthy of investment.
HIV Ally Rochelle Walensky Will Lead the CDC Under Biden. Can She Rehab the Agency After Four Years of Trump?
Walensky is an expert on implementing health care solutions and is widely respected among HIV advocates. She’s also the second recent senior CDC hire who’s white, at a time when health crises are hitting people of color especially hard.